Acuamark Diagnostics
Steven M. Lipkin is a - Professor - Weill Cornell Medicine. University of California San Diego in 1995, Board Certified. Internal Medicine Duke University, Board Certified. He is with the Clinical Genetics National Human Genome Research Institute, Recognized authority on colorectal cancer genetics.
This person is not in the org chart
Acuamark Diagnostics
Acuamark Diagnostics (formerly iCareDx) develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable.